Skip to content

Efficacy and its determinant factors of donepezil monotherapy or combined therapy with low dose quetiapine or Yi-gan san for behavioral and psychological symptoms of dementia(BPSD): prospective observational study among hospitalized patients

Efficacy and its determinant factors of donepezil monotherapy or combined therapy with low dose quetiapine or Yi-gan san for behavioral and psychological symptoms of dementia(BPSD): prospective observational study among hospitalized patients - Efficacy of donepezil or conbined therapy with low dose quetiapin or Yi-gan san for BPSD.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000004446
Enrollment
200
Registered
2010-11-11
Start date
2010-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BPSD

Interventions

None listed

Sponsors

Ishikawa Prefectural Takamatsu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospitalized patients with BPSD Patients can be followed or observed according to the study protocol Patients or their caregivers can provide necessary information for the study

Exclusion criteria

Exclusion criteria: patient with severe or unstable physical disease

Design outcomes

Primary

MeasureTime frame
Improvement in Clinical global impression scale

Secondary

MeasureTime frame
Factors affecting efficacy of the therapy Incidence and severity of adverse effects

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026